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ABSTRACT 
 
 Traditionally, antibiotic growth promoters (AGP) have been used in food animals to 
reduce enteric inflammation and maintain intestinal homeostasis, thus improving performance.  
Due to increasing restrictions regarding the use of AGP, precise and high throughput enteric 
inflammation models and markers to search for effective alternatives are urgently needed. Oral 
administration of fluorescein isothiocyanate dextran (FITC-d) and its passage into blood can be 
used as a marker for tight junction permeability. FITC-d is a large molecule (3-5 kDa) which 
does not usually leak through the intact gastrointestinal tract barrier. However, when 
conditions disrupt the tight junctions between epithelial cells, the FITC-d molecule can 
enter circulation as demonstrated by an increase in trans-mucosal permeability associated with 
chemically induced disruption of tight junctions by elevated serum levels of FITC-d after 
oral administration. In chapter one, we evaluated the dose titration of FITC-d for optimal 
measurement of enteric inflammation in broiler chicks using the following models: a) 24h feed 
restriction (FR); b) dextran sodium sulfate (DSS); or c) rye-based diet (RBD).  In these 
experiments, FR, DSS, and RBD significantly increased (P < 0.05) serum concentrations of 
FITC-d, suggesting that FITC-d may be a good indicator of permeability as has been shown in 
some mammalian models.  In chapter two, a series of experiments were conducted to evaluate 
the effect of dexamethasone (DEX) treatment in feed on systemic (serum) FITC-d levels, total 
numbers of aerobic bacteria in liver as an index of bacterial translocation (BT), differential white 
blood cell counts, and immune organs in broiler chickens.  DEX-treated chickens showed a 
significant increase in serum FITC-d and BT, again indicating that stress increased paracellular 
leakage across the gut epithelium associated with dissolution of tight junctions. Additionally, 
heterophil/lymphocyte ratio was significantly increased and relative spleen and bursa of 
  
Fabricious weight ratios were significantly decreased in DEX-treated chicks.  These results 
provide a robust measurement model for enteric inflammation model in broiler chickens to 
further evaluate candidate non-antibiotic anti-inflammatory treatments as candidate AGPs. 
 
Key words:  fluorescein isothiocyanate dextran, feed restriction, dextran sodium sulfate, rye 
diet, dexamethasone, permeability  
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I. INTRODUCTION 
Increasing grain prices, concerns over subtherapeutic antibiotic feed additives, and 
concerns for diminished animal well-being have driven a need for new sustainable disease 
management practices and improved feed efficiency for the poultry industry.  In recent years, 
non-antibiotic feed additive and probiotic research has surged, but measuring the effect of these 
strategies has traditionally been limited to gross performance or pathological evaluation.  The 
critical need for effective antibiotic growth promoter (AGP) alternatives was the focus of a 
recent OIE/USDA conference where issues related to increasing environmental footprint of 
monogastric animal agriculture, increased costs associated with production, and decreased 
animal wellbeing were clearly associated with the current and impending loss of these important 
drugs in many parts of the world (Seal et al., 2013).   
Although the mechanism by which subtherapeutic AGP result in modulations of 
microbial presence, absence and abundance patterns within the gut are in doubt, the effects of 
inclusion of AGP are clear (Butaye et al., 2003).  Modulations of the gut microflora by AGP 
include suppression of bacterial pathogens, reduction of nutrient use, increased production of 
vitamins and other nutrients, and reduced production of ammonia (Butaye et al., 2003) and AGP 
have a profound impact on growth rate and feed efficiency, possibly through effects on 
stabilization of the microbial populations (Gunal et al., 2006).  Importantly, these AGP are 
known to reduce intestinal disease frequency and severity, reduce mortality, while reducing feed 
usage and improving rate of gain in monogastric animals, including poultry (Dibner and 
Richards, 2005).  Recent poultry research has also shown that leakage of enteric bacteria into 
circulation results in non-gastrointestinal diseases (Tellez et al., 2009; Borst et al., 2012; 
Wideman, 2013).  
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An emerging and compelling hypothesis implicates reduced enteric inflammation as an 
underlying common modality for benefits associated with the addition of AGP (Niewold, 2007).  
Intestinal imbalances, or dysbiosis, are the result of changes, such as diet, infection, or even 
stresses that affect the intestinal microflora, and inflammation is obligatorily associated with 
intestinal disease, regardless of etiology (Lambert, 2009). When dysbiosis occurs, some 
populations of bacteria are reduced or even absent, while others may become overabundant, in 
addition to increased inflammation of the intestinal tract.  Niewold (2007) compiled compelling 
evidence suggesting that the effects of AGP on gut microflora may be due to effects on gut 
inflammatory status, rather than direct effects on the microflora per se. Central to the hypothesis 
of Niewold (2007), is that AGP may not benefit animals directly through an antimicrobial effect 
because they are provided at sub-minimal inhibitory concentrations, levels known to not inhibit 
affected pathogen levels within the ingesta of poultry.  Additionally, the ability of antibiotics to 
affect growth performance, regardless of the class of antibiotics used, and their target bacterial 
populations, suggests that the effects may not be directly due to antimicrobial activity.  The 
microbial populations of the intestinal tract are immensely diverse, and the ability of an 
antibiotic targeted towards specific classes of bacteria does not explain how the activity is 
consistent throughout the entire life of animals experiencing periods of changing microbial 
populations (Lu et al., 2003).  Niewold (2007) also pointed out that many popular AGP are 
classes that accumulate in phagocytes with known attenuation of the innate inflammatory 
response.  This hypothesis is consistent with the observation that the intestinal walls of AGP-fed 
animals are thinner, which could be attributed to a reduced influx and accumulation of 
inflammatory cells (Jukes et al., 1956).   
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Some probiotics and prebiotics, as potential AGP alternatives, have been shown to 
increase performance and have anti-inflammatory effects, through a variety of mechanisms 
including increased production of volatile fatty acids (VFA), known to have profound anti-
inflammatory activity (Liu et al., 2013).  For example, work from our laboratories has indicated 
that increased VFA production was associated with lactose supplementation (Tellez et al., 1993), 
and improved production, especially in combination with specific lactic acid bacterial cultures 
(Vicente et al., 2007; Torres-Rodriguez et al., 2007a,b).  These studies have shown that 
application of these cultures reduced Salmonella colonization and improved performance of 
poultry under laboratory and field trial conditions.  Interestingly, inflammation of the gut 
mucosal epithelium has been shown as a key mechanism for mucosal colonization by several 
pathogens, and is supported by emerging data, primarily from rodent studies, indicating that 
inflammation in the gut directly results in dysbiosis where the overall diversity and abundance of 
bacteria are reduced (Craven et al, 2012). With increased inflammation, regardless of cause, 
more nutrients and colonization niches are made available to pathogens.  For example, 
Salmonella, Shigella flexneri, Vibrio cholerae, and Citrobacter rodentium may exploit 
inflammation in order to reduce competition from native microflora and promote their own 
success in colonization and pathogenesis rodent models (Stecher et al., 2007; Winter et al., 
2010).  In contrast, reduced inflammation has been associated with stabilization of beneficial 
commensal bacterial populations known to reduce  expression of inflammatory cytokines and 
reduce goblet cell size and mucus secretion, supporting the premise that inflammation is a 
precursor to dysbacteriosis and necrotic enteritis (Fraune and Bosch, 2010; Kau et al., 2011; 
Maslowski et al., 2011; Salzman, 2011). This may explain why multiple classes of antibiotics 
and effective probiotics enhance performance, and indicate that effective AGP alternatives, 
4 
 
through anti-inflammatory activity, could replace AGP for improved performance and animal 
well-being.  
Thus, measuring intestinal inflammation in the search for AGP replacements may be 
crucial to the selection process.  Availability of such assay(s), specific for intestinal 
inflammation, is also expected to be useful for identifying causes and prophylactics for 
inflammation under a variety of nutritional programs and environmental conditions.  
Development of AGP alternatives has been met with many failures due to a lack of complete 
understanding of mechanisms of action and because in vivo effectiveness is most commonly 
measured through performance trials or disease resistance studies which are imprecise and 
cumbersome for high throughput screening.  This manuscript describes attempts at establishing 
non-infectious models of enteric inflammation in broiler chickens and evaluates the use of a 
large molecular weight fluorescent marker for high-throughput screening for induction or 
amelioration of enteric inflammation. 
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II. LITERATURE REVIEW 
A. BARRIER FUNCTIONS OF THE GASTROINTESTINAL TRACT 
The mucosal barrier of the gastrointestinal tract (GIT) represents the largest body 
surface in contact with the external environment, playing a crucial role in toleration of the 
microbiome as well as nutrients and water that also need to be allowed to enter the body (Galley 
and Bailey, 2014; Pijls et al., 2013).  Barrier function is a critical aspect of gut heath.  Oxidative 
stress, poorly digestible protein or energy sources and coccidiosis are some examples that can 
cause gut barrier failure (Pastorelli et al., 2013; Sharma et al., 2007; Williams, 2005; Latorre et 
al., 2014; Tellez et al., 2014). However, as a consequence of the removal of antimicrobial 
growth promoters, new multifactorial diseases causing enteritis and gut disorders of unknown 
origin have emerged in broilers, causing negative impacts in health and performance 
(Gholamiandehkordi et al., 2007; Yegani and Korver, 2008; Castanon, 2007; Dahiya et al., 
2006).  Among them, dysbacteriosis, defined as the presence of a qualitatively and/or 
quantitatively abnormal microbiota, that promote a cascade of reactions in the GIT including 
reduced nutrient digestibility and impaired intestinal barrier function, increasing the risk of 
bacterial translocation and inflammatory responses (Teirlynck et al., 2011).  However, more 
recently, poor gut health has also been associated with bacterial chondronecrosis with 
osteomyelitis (BCO) lesions and lameness in broilers chickens and broiler breeders (Wideman 
et al., 2015; Wideman et al., 2012; Wideman et al., 2011).  On a daily basis, the intestine is 
exposed to an unlimited number of antigens including dietary components, toxins, commensal 
and pathogenic microorganisms, therefore, the GIT serves as a selective barrier to take up 
nutrients and fluids into the body, while excluding undesirable molecules and pathogens 
(Sharma et al., 2010; Groschwitz and Hogan, 2009; Pastorelli et al., 2013).  Hence, proper gut 
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barrier function is essential to maintain optimal health and balance throughout the body and 
represents the first line of defense against these foreign antigens from the environment (Jeon et 
al., 2013). The first layer of gut barrier is the extrinsic mucus layer comprised of outer layer 
associated with bacteria, loosely attached to epithelium, and an inner layer with high 
concentrations of secretory IgA and mucin which are adherent to the second layer of gut barrier, 
the intestinal epithelial cells (IECs).  The IECs are represented by a single layer of epithelial 
cells that separate the intestinal lumen from underlying lamina propria (Sakamoto et al., 2000; 
Kim and Ho, 2010; Johansson et al., 2010).  These epithelial cells must be able to rapidly 
regenerate in the event of tissue damage (Audy et al., 2012; Iizuka and Konno, 2011; 
Groschwitz and Hogan, 2009). The enterocytes are responsible for absorption of nutrients. Tight 
junctions (TJ) seal the paracellular space between adjacent epithelial cells near the apical 
surface, which regulates the permeability of the intestinal barrier by preventing paracellular 
diffusion of microorganisms and antigens across the epithelium (Ulluwishewa et al., 2011; 
Sander et al., 2005). Since IECs are the primary cell type coming into contact with the external 
environment, they act as the host’s first line of the defense. In spite of their non-hematopoietic 
derivation, IECs represent a core element of innate immunity within the gut associated 
lymphoid tissue (GALT), displaying a wide array of immune functions. In fact, IECs are able to 
recognize pathogens through the expression of innate immune receptors, release anti-microbial 
molecules, secrete a wide number of hormones, neuro transmitters, enzymes, as well as 
cytokines and chemokines that link innate and adaptive immune responses (Ballard et al., 1995; 
Alverdy et al., 2005; Edelblum and Turner, 2009).  Therefore, any direct or indirect damage on 
IECs may cause a breakdown in gut barrier and consequently, disruption of normal mucosal 
immune homeostasis that can potentially lead to uncontrolled chronic intestinal and systemic 
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inflammation (Ilan, 2012; Schulzke et al., 2009). Several investigators have described the 
pathways associated with the disruption of the protein networks that connect epithelial cells by 
inflammatory mediators (hormones, oxygen free radical species, enzymes as well as multiple 
pro inflammatory cytokines) caused by pathogens, diet ingredients or stress (Steed et al., 2010; 
Schulzke et al., 2009;  Hu et al., 2013).  Other factors can also induce gut barrier loss.  Feeding 
oxidized/unpreserved fat has been shown to increase intestinal epithelial turnover rates and 
increase apoptosis at villus tips in poultry and swine (Dibner et al., 1996).  
B. STRESS AND THE GUT-BRAIN AXIS 
The impact of the central nervous system, sometimes called the “gut-brain axis,” is not 
fully elucidated.  Clearly, there are important relationships between ingested and microbe-
manufactured chemicals, the microbes that reside in the gut, and potential effects on the brain. 
Conversely, the central nervous system can impact the GIT. In commercial poultry, genetic 
selection for growth parameters in meat type chickens gives rise to a parent stock (broiler 
breeders) that tends to lack the ability to self-regulate feed intake (Yang et al., 2011; de Jong et 
al., 2003). Nonetheless, the high body mass is associated with lameness, and high mortality 
rates (often due to skeletal and/or cardiovascular disease). In order to regulate weight gain, limit 
health risks, and also maintain high fertility, husbandry practices for the parent stock of broiler 
chickens include a high degree of feed restriction (FR)  (Rajman et al., 2006; Zulkifli et al., 
1993). However, chronic FR represents a permanent stress for any animal, particularly for birds 
with relatively high metabolic requirements, where increased plasma corticosterone 
concentrations are often associated with chronic stress observed in FR programs (Washburn et 
al., 1980; Mounier et al., 1998). Stress can induce a variety of changes in normal 
gastrointestinal function, including changes in gut motility and permeability, as well as 
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alterations in ion, fluid, and mucus secretion and absorption (Alverdy and Aoys, 1991; Collins 
and Bercik, 2009; Verbrugghe et al., 2011; Karavolos et al., 2013). Animal models of acute and 
chronic stress have shown that stress induces changes in intestinal barrier function including 
increased transcellular and paracellular intestinal permeability, caused by a temporary 
dissociation of TJ proteins (Maejima et al., 1984; Assimakopoulos et al., 2011; Koh et al., 1996; 
Matter and Balda, 2007). These changes have been linked to Mast cells, important effectors of 
the brain-gut axis that initiate a consequent release of a wide range of neurotransmitters and pro-
inflammatory cytokines, causing marked effects on gastrointestinal physiology (Bailey et al., 
2011; Groschwitz and Hogan, 2009).   
C. IMPORTANCE OF DEVELOPING A MODEL FOR GUT INFLAMMATION IN 
BROILERS 
Antibiotic as growth promoter in the feed of different animal species has been used for 
many years to improve feed efficiency and growth (Castanon, 2007). The mechanisms on how 
antibiotics can promote growth are now thought to include non-antimicrobial mechanisms such 
as the ability to reduce innate inflammatory responses (Niewold, 2007).  Indeed, some 
antibiotics have been demonstrated to inhibit one or more mechanisms of inflammation 
involving both inflammatory cells and pro-inflammatory cytokine production (Dahiya et al., 
2006).  These observations led to the emerging hypothesis that commonly-used AGP might 
reduce the negative consequences of inflammation, allowing rediversion of energy toward 
growth and muscle accretion (Niewold, 2007). Although the use of AGP in animal production 
has advantages, extensive use has of these molecules has been claimed to contribute to the 
emergence of antimicrobial resistance in zoonotic pathogens, resulting in a ban by the European 
Union (Castanon, 2007). The removal of AGP from livestock production has increased cost, 
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reduced feed efficiency and increased the incidence of some enteric diseases, which has 
encouraged the search for alternatives such as effective probiotics incidence forcing animal 
husbandry to find alternatives including probiotics (Yegani and Korver, 2008). The major 
functional effect of nutraceuticals, probiotics and/or prebiotics is the balance of both GIT 
microflora and innate immune responses, and control of pro-inflammatory and anti-
inflammatory cytokines responsible for the negative impact of inappropriate inflammation 
(Joerger, 2003).  The purpose of the present thesis was to study and develop models for 
measuring the consequence of inflammation, leaky gut, within the GIT of broiler chickens. 
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B. ABSTRACT 
Traditionally, antibiotic growth promoters (AGP) have been used in food animals to 
reduce enteric inflammation and maintain intestinal homeostasis, thus improving growth and 
performance.  Due to increasing restrictions regarding the use of AGP, precise and high 
throughput enteric inflammation models and markers to search for effective alternatives are 
urgently needed. Oral administration of fluorescein isothiocyanate dextran (FITC-d, 3-5kDa) and 
its passage into blood can be used as a marker for tight junction permeability. In study 1, 10d 
broilers were assigned to control, 24h feed restriction (FR), or dextran sodium sulfate (DSS) 
(0.75% in water for 5d), and received an oral gavage of FITC-d 2.5h before sample collection. 
FITC-d in serum and intestinal samples (duodenum and ceca) were higher (P<0.05) after FR than 
in DSS and control groups. In study 2, FR was evaluated for effect on mucosal leakage and an 
oral dose of FITC-d of 0.5, 1.1, or 2.2 mg/chick was used to measure GIT permeability at 6d of 
age. The amount of FITC-d remaining in duodenal tissue of control birds increased with dose, 
only 1.1 mg FITC-d/chick dose resulted in differences (P<0.05) between control and FR. No 
differences were noted between control and FR, regardless of FITC-d dosage in cecal recovery 
of FITC-d.  Additionally, FR increased FITC-d serum levels when compared to controls and in a 
dose-dependent manner.  Experiment 3 compared serum levels after administration of 0.55 and 
1.1 mg/chick doses of FITC-d in birds treated with FR, rye-based diet (RBD), and DSS.  
Intestinal sections were collected for FITC-d recovery in the 1.1 mg dosage group.  All 
inflammation treatments significantly increased serum FITC-d levels at both dosages.  Only FR 
resulted in increased (P<0.05) FITC-d recovery from duodenum, ileum, and ceca.  In conclusion, 
FR, DSS, and RBD affect GIT tight junction integrity, suggesting their value for enteric 
inflammation models, and FITC-d may be a good indicator of permeability.   
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C. INTRODUCTION 
The gastrointestinal tract (GIT) has numerous physiological functions including effective 
absorption of dietary nutrients and plays a key role as a barrier against enteric pathogens, thus 
integrity and repair are vital for protection of animals against disease and optimal production 
performance. The mucous layer, tight junctions between epithelial cells, and gut-associated 
lymphoid tissue help to maintain a homeostasis between dietary antigens, in addition to enteric 
pathogens and beneficial microorganisms (Van Der Hulst et al., 1998). Disruption of gut health 
and its barrier results in nonselective permeability and, could lead to malabsorption of nutrients 
and translocation of a greater amount of enteric bacteria to various internal organs which may 
lead to diseases and reduced growth performance (Quinteiro-Filho et al., 2012). Furthermore, 
increasing grain prices, concerns over subtherapeutic antibiotic feed additives (AGP), and 
concerns for diminished animal well-being have driven a need for new sustainable disease 
management practices and improved feed efficiency for the poultry industry. 
Although the mechanism by which subtherapeutic AGP result in modulations of 
microbial presence, beneficial performance effects of inclusion of AGP are clear (Butaye et al., 
2003).  Possible mechanisms by which AGP modulate gut microflora by AGP include 
suppression of bacterial pathogens, reduction of nutrient use, increased production of vitamins 
and other nutrients, and reduced production of ammonia (Butaye et al., 2003) and AGP have a 
profound impact on growth rate and feed efficiency, possibly through effects on stabilization of 
the microbial populations (Gunal et al., 2006).  Importantly, these AGP are known to reduce 
intestinal disease frequency and severity, reduce mortality, while reducing feed usage and 
improving rate of gain in monogastric animals, including poultry (Dibner and Richards, 2005). 
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In the case of poultry, it has been proposed that one benefit of AGP is functional control 
of enteric inflammation (Niewold, 2007). Niewold (2007) also pointed out that many popular 
AGP are classes that accumulate in phagocytes with known attenuation of the innate 
inflammatory response.  This hypothesis is consistent with the observation that the intestinal 
walls of AGP-fed animals are thinner (Jukes et al., 1956), which could be attributed to a reduced 
influx of inflammatory cells.  However, models of enteric inflammation are not currently well-
developed in poultry, and hinder the search for a complete understanding of the roll of AGP in 
production and alternative additives that can provide the same, or better, functions.  Thus, there 
is an urgent need to develop enteric inflammation and permeability models in poultry that can 
both aid in elucidating the performance-enhancing effects of AGP and in the search for 
alternatives. 
Recent publications describing rodent models of enteric inflammation and leaky gut have 
described fluorescein isothiocyanate–dextran (FITC-d) as a marker of enteric leakage (Shah et 
al., 2007; Brandl et al., 2009; Yan et al., 2009). Yan et al. (2009) demonstrated an increase in 
pericellular leakage associated with dextran sodium sulfate (DSS) treatment by measuring the 
serum levels of FITC-d 4h after FITC-d oral gavage. Similarly, starvation in mice resulted in 
reduced gut epithelial cell proliferation and increased apoptosis (Chappell et al., 2003). These 
findings suggest that induction of gut inflammation and measurement of gut leakage using FITC-
d could be an effective method to study gut health. 
The studies herein were designed to evaluate multiple inducers of enteric inflammation 
and dosages of FITC-d as a marker of leaky gut.  Feed restriction (FR) is a common practice for 
breeder stock because genetic selection for growth parameters in meat type chickens gives rise to 
a parent stock (broiler breeders) that tends to possess high body mass associated with excessive 
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fat deposition, lameness, and high mortality rates often due to skeletal and/or cardiovascular 
disease. In order to regulate weight gain, limit health risks, and also maintain high fertility, 
husbandry practices for the parent stock of broiler chickens include a high degree of FR (Lee et 
al., 1971; Yu et al., 1992).  Well-being and disease susceptibility during FR are a concern for 
producers, thus FR was evaluated for its impact on enteric permeability.  Additionally, 
alternative feedstuffs such as wheat and rye are not uncommon, and often contain high levels of 
non-starch polysaccharides (NSP; Choct et al., 1995).  Such diets often lead to higher 
susceptibility to necrotic enteritis and increased digesta viscosity (Annett et al., 2002; Tellez et 
al., 2014).  The purpose of the present studies was to evaluate alterations in gut permeability 
under inflammation and stress induced by FR, high NSP diet, or DSS, previously studied 
inducers of leaky gut in broilers (Kuttappan et al., 2014a, b; Latorre et al., 2014; Menconi et al., 
2014; Tellez et al., 2014). Additionally, multiple doses of FITC-d were evaluated for serum and 
intestinal recovery to help optimize optimal detection of gastrointestinal permeability as a marker 
of enteric inflammation. 
D. MATERIAL AND METHODS 
Experimental Animals 
Day of hatch broiler chicks were obtained from a primary breeder and randomly assigned 
to treatment groups.  Chicks were housed in brooder battery cages with wire floors. Throughout 
each experiment, chicks were provided a diet that met or exceeded NRC requirements (National 
Research Council, 1994), except FR groups, and water ad libitum throughout the research period.  
A previously determined dose for drinking water administration of DSS (MW 40,000; Alfa 
Aesar, Ward Hill, MA) was provided as a 0.75% solution ad libitum as described below in 
experimental design (Menconi et al., 2014).  The rye-based diet (RBD) was formulated as 
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previously described as an inducer of leaky gut, and both control and rye-based diet are 
described in Table 1 (Tellez et al., 2014).  Rye diet was provided as the sole source of nutrition 
during d5-d7 in Experiment 3, described below.   
To detect enteric leakage, chickens were dosed with FITC-d (MW 3,000-5,000; Sigma 
Aldrich Co., St. Louis, MO) by oral gavage at concentrations described below.  Previous 
unpublished data has suggested that 2.5h after oral gavage with FITC-d is the optimal blood 
collection time point for broilers.  Birds were killed by CO2 inhalation, and blood and intestinal 
tissue samples were collected post-mortem. All animal handling procedures were in compliance 
with Institutional Animal Care and Use Committee regulation at the University of Arkansas.   
FITC-d Fluorescence in Blood 
For detection of FITC-d in serum, blood was kept at room temperature for 3h to allow 
clotting, and centrifuged (1,000Xg for 15min) to separate serum. Fluorescence levels of diluted 
serum (1:1 in PBS) were measured at excitation wavelength of 485nm and emission wavelength 
of 528nm (Synergy HT, Multi-mode microplate reader, BioTek Instruments, Inc., Vermont, 
USA), and FITC-d concentration per mL of serum was calculated based on a standard curve. 
Tissue Levels of FITC-d  
Measurement of FITC-d released from intestinal tissue was accomplished by collection 
of 2.5 cm sections of GIT which were cleaned by flushing with Hanks buffered salt solution, 
weighed and placed in tubes with 10mL of Hanks buffer containing glutamine (0.3g/L) and 
antimicrobial agents (Penicillin 100µ/mL; Streptomycin 0.01mg/mL; Amphotericin B 
0.25µg/mL).  Duodenal samples were collected from the descending duodenum, ileal samples 
from immediately proximal to the Meckel’s diverticulum, and a single entire cecum for tissue 
sampling.  The tubes were incubated for 2h at 42°C and sampled by collecting 100µL of buffer 
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from each tube. FITC-d levels of buffer in the tubes were determined by fluorescence 
measurement as described above for serum, with the final concentration reported as µg/g of ileal 
tissue. 
Experimental Design 
Experiment 1. Evaluation of feed restriction and Dextran sodium sulfate on enteric 
leakage.  Thirty chicks were comingled in a single wire-floor brooder battery cage through d10, 
at which point they were randomly separated into three separate cages according to treatment 
group (n=10/group) – control (CON), FR, or DSS for the remainder of the experiment.  On d10, 
DSS group began receiving 0.75% DSS in drinking water, and continued treatment through the 
end of the experiment.  On d13 FR began and continued for 24h through the end of the 
experiment.  Fluorescein isothiocyanate–dextran (2.2 mg/bird) for serum detection was 
administered by oral gavage on d14. 
 Experiment 2.  Evaluation of three doses of FITC-d in serum and GIT tissue after feed 
restriction.  Forty-eight day of hatch chicks were randomly separated into wire-floor brooder 
battery cages (24 chicks/cage) and reared with feed and water ad libitum through d5.  On d6 feed 
was removed from one group, FR, for the remainder of the experiment (24h).  Concentrations of 
FITC-d at 0.55 mg/chick, 1.1 mg/chick, or 2.2 mg/chick were administered by oral gavage to 8 
chicks each in CON and FR groups on d7.  Blood, duodenum, and ceca were collected 2.5 h after 
administration of FITC-d. 
Experiment 3.  Evaluation of two doses of FITC-d in serum and GIT tissue after feed 
restriction, DSS, or rye-based diet.  Eighty day of hatch chicks were randomly separated into 
wire-floor brooder battery cages (20 chicks/cage) and reared with feed and water ad libitum 
through d5.  On d5, 0.75% DSS treatment in drinking water or RBD were initiated for two cages 
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and continued throughout the remainder of the experiment. On d6 feed was removed from one 
group, FR, through termination of the experiment (24 h).  Concentrations of FITC-d at 0.55 
mg/chick, or 1.1 mg/chick were administered by oral gavage to 10 chicks each in CON, FR, 
DSS, and RBD groups on d7.  Blood was collected from all groups, plus duodenum, ileum, and 
ceca were collected from 1.1 mg/chick FITC-d group 2.5 h after administration of FITC-d. 
Statistical Analysis 
Data were analyzed using ANOVA (SAS 9.3, SAS Institute Inc., Cary, NC), and means 
were separated with Duncan’s significant difference test with P < 0.05 considered as significant. 
Individual birds were considered as the experimental unit for the entire analysis. In all trials, data 
are expressed as mean ± standard error.  
Data from serum FITC-d levels were analyzed in 2 X 2 factorial (Treatment X Dose) 
using JMP Pro 11.2.0 (SAS Institute Inc.) and main effects of treatment, dose, and interaction 
between treatment and dose were evaluated. Serum FITC-d data showed occasional, but random, 
high values which were not representative of the respective group means. Although, the reason/s 
for such high FITC-d values is/are still not clear, it does not seem to be related to treatment. 
Since these values were creating noise in analysis, outliers from treatment groups were identified 
as above or below two standard deviations from mean, based on empirical or 68-95-99.7 rule. 
Identified outliers were trimmed, or truncated, according to (Ghosh and Vogt, 2012). Analysis of 
Experiments 2 and 3 serum (0.55 and 1.1 mg/chick doses) from CON and FR were completed 
both with unedited and truncated data, and results are reported as mean ± standard error (SE) and 
P values for the respective main effects to describe this phenomenon. Main effects with P-value 
less than 0.05 were considered significant.  All other reported data for serum and tissue samples 
represents truncated values, with number of outliers removed reported. 
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E. RESULTS 
Serum FITC-d 
 Various inducers of leaky gut were compared for ability to increase FITC-d passage into 
serum, including FR, DSS, and RBD.  In experiment 1, both FR and DSS, with recovery levels 
of 0.364±0.017 and 0.279±0.01 µg/mL respectively, resulted in higher (P<0.05) levels of FITC-d 
(2.2mg/bird) than control chicks at 0.182±0.015 µg/mL (Table 2).  Feed restriction also caused 
higher (P<0.05) levels of serum FITC-d than controls, at 0.218±0.007 vs. 0.131±0.02 µg/mL, in 
experiment 2 when administered at 0.55mg/bird, but not at other doses.  Additionally, all three 
tested enteric inflammation treatments – FR, RBD, and DSS, showed significantly increased 
FITC-d recovery compared to control serum, regardless of FITC-d dose in experiment 3. 
Furthermore, multiple doses of FITC-d were tested to determine optimal concentration 
for measuring enteric leakage.  In experiment 2, three doses, 0.55 mg/bird, 1.1 mg/bird, and 2.2 
mg/bird were evaluated after 24h FR, with 0.55 mg FITC-d/bird being the only dose that resulted 
in significant difference from controls with recovery levels at 0.218±0.007 µg/mL in FR group 
and 0.131±0.02 µg/mL in the control group (Table 2).  It was also noted that as FITC-d dosage 
increased, the level of recovery from control serum also rose in a dose-dependent manner of 
0.131±0.014, 0.201±0.035, and 0.302±0.032 µg/mL of serum for 0.55, 1.1, and 2.2 mg FITC-
d/bird, respectively.  Also, the difference between control and FR groups became less apparent 
as mg of FITC-d increased (Figure 1B).  While 0.55 mg/bird dose of FITC-d also resulted in 
significant differences from control in Experiment 3, 1.1 mg/bird dose of FITC-d resulted in the 
greatest difference from control for FR, RBD, and DSS in Experiment 3 (Table 2). 
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Tissue FITC-d 
 Experiments 2 and 3 evaluated tissue recovery of FITC-d by oral gavage to help 
determine which regions of GIT are affected by each method of induction.  Three doses of FITC-
d, 0.55, 1.1, and 2.2 mg/bird, were tested for recovery in duodenum and cecum in Experiment 2.  
Only the dosage of 1.1 mg/bird of FITC-d results in a significant (P<0.05) difference from 
control after 24h FR, with 1.245±0.071 µg/g and 1.709±0.176 µ/g of tissue in control and FR 
groups, respectively (Table 4).  No differences were measured between control and FR in cecal 
levels of FITC-d.  In contrast, FR increased recovery of FITC-d from tissue in all three GIT 
tissues in Experiment 3, in which only 1.1 mg/bird FITC-d was measured.  Duodenum tissue 
recovery increased from 1.267±0.217 µg/g in control birds to 3.057±0.288 µg/g in FR birds, 
ileum recovery of FITC-d was 3.541±0.664 µg/g for control group vs. 11.40±3.099 µg/g in FR 
group, and cecal increased from 6.082±0.916 µg/g in control birds to 15.071±1.943 µg/g in FR 
birds.  Both RBD and DSS failed to result in elevated FITC-d tissue recovery for all intestinal 
sections. 
F. DISCUSSION 
Increasing grain prices, concerns over subtherapeutic antibiotic feed additives, and 
concerns for diminished animal well-being have driven a need for new sustainable disease 
management practices and improved feed efficiency for the poultry industry.  In recent years, 
non-antibiotic feed additive and probiotic research has surged, but measuring the effect of these 
strategies has traditionally been limited to gross performance or pathological evaluation.  The 
critical need for effective AGP alternatives was the focus of a 2012 OIE/USDA conference 
where issues related to increasing environmental footprint of monogastric animal agriculture, 
increased costs associated with production, and decreased animal wellbeing were clearly 
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associated with the current and impending loss of these important drugs in many parts of the 
world (Seal et al., 2013). The ongoing diminution of AGP usage is estimated to reduce feed 
efficiency of monogastric animals by approximately 6-10% (reviewed by Thomke and Elwinger, 
1998; Bedford, 2000).    
Although the mechanism by which subtherapeutic AGP result in modulations of 
microbial presence, absence and abundance patterns within the gut are in doubt, the effects of 
inclusion of AGP are clear (Butaye et al., 2003).  Modulations of the gut microflora by AGP 
include suppression of bacterial pathogens, reduction of nutrient use, increased production of 
vitamins and other nutrients, and reduced production of ammonia (Butaye et al., 2003) and AGP 
have a profound impact on growth rate and feed efficiency, possibly through effects on 
stabilization of the microbial populations (Gunal et al., 2006).  Importantly, AGP are known to 
reduce intestinal disease frequency and severity, reduce mortality, while reducing feed usage and 
improving rate of gain in monogastric animals, including poultry (Dibner and Richards, 2005).   
An emerging and compelling hypothesis implicates reduced enteric inflammation as an 
underlying common modality for benefits associated with the addition of AGP (Niewold, 2007).  
Intestinal imbalances, or dysbiosis, are the result of changes, such as diet, infection, or even 
stressors that affect intestinal microflora.  The resulting inflammation from these imbalances is 
thus obligatorily associated with intestinal disease, regardless of etiology (Lambert, 2009). 
Niewold (2007) also noted that many popular AGP are classes that accumulate in phagocytes and 
are known to diminish innate inflammatory responses.  This hypothesis is consistent with the 
observation that the intestinal walls of AGP-fed animals are thinner (Jukes et al., 1956), which 
could be attributed to a reduced influx and accumulation of inflammatory cells.  While it is well-
known that intestinal microflora are important potentiators of the intestinal host defenses, 
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modulation of inflammatory responses is critical, as common production problems related to 
inflammation are commonly related to an excessive, rather than insufficient, innate immune 
response (McCracken and Gaskins, 1999; Tracey, 2002). 
Thus, measuring intestinal inflammation in the search for AGP replacements may be 
crucial to the selection process.  Availability of such assay(s), specific for intestinal 
inflammation, is also expected to be useful for identifying both causes and preventatives for 
inflammation under a variety of nutritional programs and environmental conditions.  Animal 
models for human GIT diseases, such as irritable bowel disorder (IBD), have been previously 
developed, and have well-established measurement protocols (Yan et al., 2009).   A common 
molecule for quantification of enteric inflammation is FITC-d, a molecule which does not 
usually leak through the intact gastrointestinal tract barrier (Rose et al., 2012).  However, when 
conditions disrupt tight junctions between epithelial cells, FITC-d can enter circulation, as 
demonstrated by an increase in trans-mucosal permeability associated with enteric inflammation 
treatment in these studies.  Progressive detection of FITC-d in serum (Table 2) and gut tissue 
retention (Table 4) is consistent with leakage from the lumen and suggests the presence of a 
change in paracellular permeability rather than transcellular transport. Ex vivo evaluation of GIT 
permeability has been used as a method to determine gut leakage in animal models. For many of 
such studies, either an everted or non-everted intestinal section and a marker dye, like FITC-d or 
phenol red in buffer, and the rate of passage of dye across intestinal walls was estimated to 
determine gut leakage (Nakamaru et al., 1997; Lambert, 2009; van der Meer et al., 2012).  
Specially designed apparati, such as Ussing chambers, are required to perform some permeability 
assays, which are slow and often lead to low number replications in experimental results (Dixit et 
al., 2012), and are obviously devoid of circulatory, endocrine, and cytokine feedback 
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mechanisms.  The present studies suggest that decreased mucosal integrity can be measured in 
the simple FITC-d assay as described.  
Occasional outliers were noted in both serum and tissue FITC-d detection assays, and 
were presently reported with their inclusion or after removal from reported values when outliers 
were ± 2 standard deviations from the mean, as described by Ghosh and Vogt (2012; Figure 1 
and Table 3).  These random extremely high values created noise in data that made interpretation 
difficult, and although the cause of these outliers is not yet known, they do not seem related to 
FITC-d dose or treatment, as shown in Table 3.  Treatment X dose interaction was not significant 
for either truncated or unedited data in Experiment 2 and 3, but removal of outliers did 
occasionally change the P-value from P>0.05 to P<0.05, as shown for Experiment 2 treatment 
values.  Furthermore, removal of two outliers from Experiment 2 changed a dose response curve 
that was uninterpretable (Figure 1A) to one that followed expected results and can be interpreted 
to discern appropriate dosage for FITC-d detection of enteric leakage (Figure 1B).  In fact, the 
curve presented in Figure 1B suggests that tested doses of FITC-d may be at the top of the dose-
response curve, and further testing of lower concentrations may be warranted, because 0.55 
mg/kg was the only concentration on the linear portion of the curve, and without truncation, this 
observation would not have been noted. 
While 1.1 mg/kg FITC-d was the only concentration tested that resulted in significant 
differences in tissue recovery (Table 4), a lower dose of 0.55 mg/kg FITC-d appeared to more 
consistently result in a greater difference from the mean for serum samples (Table 2).  Feed 
restriction effects, as measured at 0.55, 1.1, and 2.2 mg/kg FITC-d, were 166%, 141%, and 128% 
greater than the respective control values for Experiment 2, suggesting that background leakage 
decreases with FITC-d dose, a primary objective of these studies.  Although regional enteric 
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effects of the selected insults was not a primary goal of the present studies, tissue evaluation of 
regional enteric FITC-d provided some insight into relative inflammation of selected portions of 
the GIT. 
  These studies suggest that circulating levels of FITC-d can be used for rapid evaluation 
of inflammatory-associated enteric epithelial leakage, which may be useful in the search for AGP 
alternatives in future studies.  Future evaluation and comparison of regional FITC-d recovery 
with specific enteric pathogen-induced enteric inflammatory insults may allow for determination 
of the value of FITC-d tissue retention following post-mortem sample collection, which may 
have value for diagnostic or investigations related to idiopathic infectious etiologies.  
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 Table 1 Ingredients (%) of corn and rye diets.  
 
Ingredient Corn diet Rye diet 
Ingredients   
Corn 55.53 0.0 
Rye 0.00 58.27 
Soybean meal 35.69 31.16 
Vegetable oil 4.22 6.29 
Dicalcium phosphate 1.82 1.79 
Calcium carbonate
 1.12 1.05 
Salt 0.38 0.38 
DL-Methionine 0.37 0.35 
Vitamin premix
1 0.20 0.20 
L-Lysine HCl 0.28 0.22 
Choline chloride 60% 0.20 0.10 
Mineral premix
2
 0.10 0.10 
Selenium 0.6% 0.02 0.02 
Propionic acid 0.02 0.02 
Antioxidant 0.05 0.05 
Total 100.00 100.0 
1
Vitamin premix supplied the following per kg: vitamin A, 20,000,000 IU; vitamin D3, 
6,000,000 IU; vitamin E, 75,000 IU; vitamin K3, 9 g; thiamine, 3 g; riboflavin, 8 g; pantothenic 
acid, 18 g; niacin, 60 g; pyridoxine, 5 g; folic acid, 2 g; biotin, 0.2 g; cyanocobalamin, 16 mg; 
and ascorbic acid, 200 g  (Nutra Blend LLC, Neosho, MO 64850). 
2
Mineral premix supplied the following per kg: manganese, 120 g; zinc, 100 g; iron, 120 g; 
copper, 10–15 g; iodine, 0.7 g; selenium, 0.4 g; and cobalt, 0.2 g (Nutra Blend LLC, Neosho, 
MO 64850). 
3
 Ethoxyquin. 
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Table 2 Serum FITC-d levels after enteric inflammation treatments of dextran sodium sulfate 
(DSS), feed restriction (FR), or rye diet (RBD). DSS was administered in drinking water for 5 
days, FR was conducted for 24 h, and RBD provided for 3 days before oral gavage with FITC-d 
on d14, blood was collected 2.5 h post-gavage. Values reported as mean ± standard error. 
 
FITC-d Dose Treatment 
Serum FITC-d 
(µg/mL) Mean±SE 
# Outliers 
Removed
1
 
Experiment 1    
2.2mg/bird Control 0.182±0.015
c
  
 FR 0.364±0.017
a
  
 DSS 0.279±0.010
b
 1 
Experiment 2  
 
 
0.55mg/bird Control 0.131±0.020
b
  
  FR 0.218±0.007
a
  
1.1mg/bird Control 0.201±0.035
a
 1 
  FR 0.283±0.020
a
  
2.2mg/bird Control 0.234±0.026
a
  
  FR 0.302±0.032
a
 1 
Experiment 3  
 
 
0.55mg/bird Control 0.193±0.014
b
 1 
  FR 0.281±0.017
a
 1 
 RBD 0.288±0.047
a
 1 
 DSS 0.281±0.016
a
 1 
1.1mg/bird Control 0.163±0.023
c
 1 
 FR 0.307±0.022
a
 1 
 RBD 0.224±0.009
b
 1 
 DSS 0.251±0.013
b
  
1
 Data was truncated to remove outliers ±2SD from the group mean 
a-c
values with different superscripts within each experiment and treatment dose 
are significantly different (P<0.05) 
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Table 3 Effect of treatment (control or feed restriction, FR), dose of FITC-d (0.55 or 1.1 
mg/chick), and interaction between treatment and dose on serum FITC-d (µg/mL) levels in 
Experiments 2 and 3.  FR was conducted 24h immediately prior to oral gavage with FITC-d, 
blood samples were collected 2.5h after dosage for detection.  Serum FITC-d levels reported as 
mean ± SE (µg/mL). 
 
FITC-d Dose  Experiment 2 Experiment 3 
 With Outliers Truncated With Outliers Truncated 
0.55 mg/bird Control 0.131±0.022 0.131±0.020 0.227±0.036 0.193±0.014 
  FR 0.218±0.008 0.218±0.007 0.299±0.024 0.281±0.017 
1.1 mg/bird Control 0.278±0.089 0.201±0.035 0.216±0.057 0.163±0.023 
  FR 0.283±0.022 0.283±0.020 0.334±0.033 0.307±0.022 
Pooled SE  0.04 0.02 0.04 0.02 
P-value      
Treatment 0.3016 0.0007* 0.0211* <0.0001* 
Dose  0.0234* 0.0049* 0.7616   0.9222 
Treatment X Dose 0.3609 0.9178 0.5737   0.149 
 *significant (P<0.05) effect of the main effect/s  
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Table 4 Tissue recovery of FITC-d (µg/g tissue) from duodenum, ileum, and cecum from 
broilers after enteric inflammation treatment.  2.5h after FITC-d administration by oral gavage, 
chicks were killed and tissue sections incubated in Hank’s Buffer for 2.5h.  Levels reported are 
µg of FITC-d recovered from incubation buffer per g of tissue, truncated mean ± SE (±2SD 
outliers removed). FR = 24h feed restriction, RBD = rye based diet, DSS = 0.75% DSS in 
drinking water.  
 
FITC-d Dose Duodenum Ileum Cecum 
Experiment 2    
0.55mg/bird Control 1.042±0.111
a
 -ND- 3.220±0.583
a
 
 FR 1.694±0.375
a
 -ND- 6.307±2.201
a
 
1.1 mg/bird Control 1.245±0.071
b
 -ND- 6.310±1.177
a
 
 FR 1.709±0.176(1)
a
 -ND- 6.104±0.405(1)
a
 
2.2mg/bird Control 1.832±0.357
a
 -ND- 6.390±0.713
a
 
 FR 1.837±0.197(1)
a
 -ND- 6.813±2.450
a
 
Experiment 3 
 
  
1.1 mg/bird Control 1.267±0.217
b
 3.541±0.664
b
 6.082±0.916
b
 
 FR 3.057±0.288
a
 11.40±3.099
a
 15.071±1.943
a
 
 RBD 2.620±0.148(1)
a
 4.915±0.881(1)
b
 5.918±1.783
b
 
 DSS 2.575±0.247
a
 5.221±0.866
b
 5.829±0.554
b
 
ND = no data collected 
a-b 
values with different superscripts within each experiment, tissue, and treatment dose are 
significantly different (P<0.05)  
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Figure 1 Detection of FITC-d in serum after 24h feed restriction (FR) without (A) and with (B) 
truncation of ± 2 SD from mean.  Chickens were subjected to 24h FR immediately prior to oral 
gavage with 0.55, 1.1, or 2.2 mg FITC-d and blood collected 2.5 h post-gavage (Experiment 2). 
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B. ABSTRACT 
We have previously shown that intestinal barrier function can be adversely affected by 
poorly digested diets or feed restriction, resulting in increased intestinal inflammation-associated 
permeability. Three experiments were conducted to evaluate the effect of dexamethasone (DEX) 
treatment on systemic Fluorescein isothiocyanate-dextran (FITC-D; 3-5kDa) levels, indicative of 
increased gut epithelial leakage. Exp 1 compared DEX injections of 1 mg/kg, once per day, on 
d3, 5, and 9 with feed administration at 0.57, 1.7, or 5.1 ppm d4-10, on FITC-D serum 
concentrations 2.5 h after gavage with 4.16 mg/kg FITC-D.  All DEX treatments resulted in 
marked (2-6X; P<0.05) increased serum FITC-D levels. Feed DEX administration resulted in 
greater (P<0.05) gut permeability than injection at any dose, with numerically optimal effects at 
the lowest dose tested.  In Exp 2-3, chicks were randomly assigned to starter ration containing 
either control (CON) or DEX treated feed (0.57 ppm/kg; d3-10 Exp 2, d4-10 Exp 3).  At d10, all 
chicks were treated by oral gavage with FITC-D and serum samples were obtained as described 
above. Samples of the liver were aseptically collected, homogenized, diluted 1:4 wt/vol in sterile 
saline, and serial dilutions were plated on tryptic soy agar to evaluate total numbers of aerobic 
bacteria in liver as an index of bacterial translocation (BT).  In both experiments, FITC-D 
absorption was significantly enhanced (P<0.05) in DEX-treated chicks, again indicating 
increased paracellular leakage across the gut epithelium associated with dissolution of tight 
junctions. Exp 2 differential cell counts showed an increased heterophil/lymphocyte ratio, and 
immune organ (spleen and bursa of Fabricius) weights for Exp 2 and 3 were decreased (P<0.05) 
from controls. In Exp 2 and 3, dietary DEX administration resulted in numerically (Exp 2) or 
significantly (P<0.05) increased enteric BT to the liver, supporting the observation that dietary 
DEX causes a stress-like inflammatory GI response, which may contribute to subclinical or 
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clinical disease, and may be a useful model for ongoing disease mitigation research related to 
stress-related diseases of GIT origin. 
Key words  Chickens, dexamethasone, stress, bacterial translocation, permeability  
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C. INTRODUCTION 
The intestinal mucosa consists of a single layer of epithelial cells that serves multiple 
functions including secretion of mucus and enzymes, absorption of nutrients, and barrier function 
between external and internal environments.  Thus, maintenance of epithelial integrity, from both 
nutrition and disease perspectives, is a major component of rearing healthy feed efficient poultry. 
Barrier function is influenced by a variety of factors such as enzymes, infectious agents, toxins, 
and hormones (Söderholm and Perdue, 2001; Lamprecht and Frauwallner, 2012).  Continuity of 
the epithelium is important for controlling both paracellular and transcellular permeability, and is 
largely controlled by tight junction (TJ) distribution and integrity.  Animal models of acute and 
chronic stress have demonstrated induced changes in intestinal permeability associated with a 
temporary redistribution of TJ (Maejima et al., 1984; Matter and Balda, 2007). Other enteric 
changes associated with stress include gut motility, permeability, and alterations to ion, fluid, 
and mucus secretion (Alverdy and Aoys, 1991; Karavolos et al., 2008). 
These changes have been linked to Mast cells which are important effectors of the brain-
gut axis and translate stress signals into the release of a wide range of neurotransmitters and pro-
inflammatory cytokines, with dramatic effects on gastrointestinal physiology (Groschwitz and 
Hogan, 2009; Bailey et al., 2011; Lamprecht and Frauwallner, 2012).  Studies have shown that 
dexamethasone can modulate enteric tight junction integrity (Boivin et al., 2007; Tenenbaum et 
al., 2008), but it is also regularly used as an inducer of opportunistic diseases with translocation 
of bacteria from the gastrointestinal tract to blood circulation (McGruder et al., 1995; Huff et al., 
1999; Wideman and Pevzner, 2012). Studies in poultry directly testing effects dexamethasone on 
enteric permeability have yet to be reported, though studies using dexamethasone for induction 
of skeletal diseases with etiologies partially involving enteric bacteria have been published (Huff 
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et al., 1998; Wideman and Pevzner, 2012). We have previously shown that intestinal barrier 
function can be adversely affected by poorly digested diets (Tellez et al., 2014) and feed 
restriction (Kuttappan et al., 2014; Vicuña et al., 2014), resulting in increased intestinal 
inflammation-associated permeability. The purpose of the present study was to evaluate the 
alterations in gut permeability under stress induced by administration of dexamethasone in feed 
in broiler chicks. 
D. MATERIAL AND METHODS 
Experimental Animals and Diets   
Three experiments were conducted to evaluate the effect of stress on intestinal 
permeability induce by administration of dexamethasone in feed. In all experiments, broiler 
chickens were obtained from Cobb-Vantress (Siloam Springs, AR, USA).  For each experiment, 
chickens were randomly assigned to control or dexamethasone groups.  Chickens were placed in 
a controlled age-appropriate environment with unrestricted access to feed and water. In each 
experiment, chickens received an antibiotic free corn/soybean based diet meeting the nutritional 
requirements of poultry recommended by National Research Council  (1994).  All animal 
handling procedures were in compliance with Institutional Animal Care and Use Committee at 
the University of Arkansas.  
Serum determination of FITC-D leakage 
Fluorescein isothiocyanate dextran (FITC-D; MW 3-5 KDa; Sigma Aldrich Co., St. 
Louis, MO) levels were detected in serum. After collection from chickens, blood was kept at 
room temperature for 3h, centrifuged (1,000 X g for 15 min) to separate serum from red blood 
cells, and diluted 1:1 in PBS. Levels of FITC-D in serum were measured at excitation 
wavelength of 485 nm and emission wavelength of 528 nm (Synergy HT, Multi-mode microplate 
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reader, BioTek Instruments, Inc., Vermont, USA). Fluorescence measured was then compared to 
a standard curve with known FITC-D concentrations. Gut leakage for each bird was reported as 
μg of FITC-D/mL of serum.   
Bacterial translocation 
To measure bacterial translocation (BT) from the intestinal tract to blood circulation, the 
right half of the liver was aseptically removed from each chicken, collected in sterile bags, 
homogenized, weighed and 1:4 wt/vol dilutions were made with sterile 0.9% saline. Serial 
dilutions of each sample were made and plated on tryptic soy agar for determination of total 
aerobic bacteria translocation levels (TSA, catalog no. 211822, Becton Dickinson, Sparks, MD).  
Experiment 1 
Day of hatch broiler chicks were randomly assigned to 5 groups (n = 25).  The aim of this 
experiment was to compare dexamethasone injection (DEXINJ) at a known stress-response-
inducing dose of 1 mg/kg of BW (positive control) on d3, d5, and d9 to feed administration of 
dexamethasone at 0.57 ppm (DEXF1X), 1.71 ppm (DEXF3X), or 5.13 ppm (DEXF9X) for d4-
10 of the experiment.  This dosage was based on calculations that would provide approximately 
1 mg/kg of BW daily by oral consumption for DEX1X treatment. A control group without 
dexamethasone was included as a negative control.  Effects on enteric permeability were 
measured by FITC-D serum concentrations.  At d10, chickens in all treatment groups were given 
an oral gavage dose of FITC-D (4.16 mg/kg), and killed by CO2 inhalation 2.5h later for blood 
collection from the femoral vein.   
Experiment 2 
Day of hatch broilers were weighed and randomly assigned (n = 25) to wire floor 
brooders with a starter ration.  On d3, the DEXF treatment group was changed to feed containing 
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DEXF1X (0.57 ppm) for the remainder of the experiment.  At d10, all chickens were weighed 
and blood samples were collected after CO2 asphyxiation from the femoral vein of 12 chickens 
from each group.  Differential cell counts were conducted with a Cell-Dyne 3500 System 
(Abbott Laboratories, Chicago, IL) that has been standardized for differential counts of poultry 
blood. Hematologic measurements of heparin anti-coagulated blood included total counts of 
white blood cells (WBC), heterophils, lymphocytes, monocytes, eosinophils, and basophils. 
Heterophil/lymphocyte ratios (H/L), an indicator of stress in birds (Gross and Siegel, 1983), were 
calculated by dividing the number of heterophils in 1 mL of peripheral blood by the number of 
lymphocytes.  The remaining chickens in both groups were orally gavaged with FITC-D and 
serum samples were obtained 2.5h post-gavage and liver samples collected for BT measurement, 
as described above. Spleen and bursa of Fabricius were removed and cleaned of adherent tissues. 
The weight of both organs was measured and expressed as relative to final body weight ((organs 
weight/final BW) × 100).  
Experiment 3 
Day of hatch broilers were weighed and randomly assigned (n = 25) to wire floor 
brooders with a starter ration.  On d4, the DEXF treatment group was changed to feed containing 
DEX1X for the remainder of the experiment.  On d10 all chickens were weighed and orally 
gavaged with FITC-D. Blood samples were obtained 2.5h post-gavage and liver samples 
collected for BT measurement, as described above. Spleen and bursa of Fabricius were removed 
and cleaned of adherent tissues. The weight of organs were measured separately and expressed 
as relative to final body weight ((organs weight/final BW) × 100).  
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Statistical analysis 
Serum FITC-d data showed occasional, but random high values which were not 
representative of respective group means. Although the reason/s for such high FITC-D values are 
still not clear, it does not seem to be related to our treatments. Since these values were creating 
noise in analysis, outliers from treatment groups were identified as above or below two standard 
deviations from the mean, based on empirical or 68-95-99.7 rule. Identified outliers were 
truncated according to Ghosh and Vogt (2012) and the number of removed samples reported 
below.  Samples removed due to high FITC-D levels were not included for all other data 
analysis. All data were subjected to Analysis of Variance (Experiment 1) or One Way Analysis 
of Variance (Experiments 2 and 3) as a completely randomized design using the General Linear 
Models procedure of SAS (SAS Institute, 2002).  In all trials, data are expressed as mean ± 
standard error. Significant differences among the means were determined by using Duncan’s 
multiple-range test at P < 0.05. 
E. RESULTS 
 Three levels of DEXF were tested and compared to DEXINJ or negative control for 
ability of dexamethasone administered in feed for seven days to affect intestinal mucosal leakage 
as measured by FITC-D.  Each feed inclusion treatment, DEXF1X (0.57 ppm), DEXF3X (1.71 
ppm), and DEXF9X (5.13 ppm) resulted in 0.300±0.026, 0.276±0.016, and 0.256±0.010 µg/mL 
FITC-D in serum, respectively, compared to 0.059±0.011 µg/mL in negative control and 
0.126±0.012 µg/mL in DEXINJ (Figure 1).  All groups except negative control were truncated 
by removal of one sample <2SD from the group mean. Each DEXF group was statistically higher 
than control and DEXINJ, suggesting that indicating increased paracellular leakage across the 
gut epithelium associated with dissolution of tight junctions, however treatment-associated 
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clinical signs, such as lethargy and pallor, and mortality were noted in DEXF3X and DEXF9X 
(data not shown). Similarly, serum FITC-D significantly increased from 0.22±0.01 in control 
group to 0.29±0.03 in DEXF group for experiment 2 (Table 1) and from 0.33±0.01 in controls to 
0.63±0.04 in DEXF for experiment 3 (Table 3).  One sample from each group was removed for 
truncation (<2SD) in experiment 2 and no samples were truncated for experiment 3. 
Detectable total liver aerobic bacteria was significantly (P<0.05) higher at 0.00±0.00 vs. 
1.26±0.45 Log10 in experiment 2 (Table 1), and 0.00±0.00 vs. 2.58±0.35 Log10 (Table 3) 
supporting the observation that dietary DEX causes a stress-like inflammatory GI response. Final 
BW and BWG were significantly decreased in DEXF groups in experiments 2 and 3 (Table 1, 
Table 3).  Similarly, relative spleen and bursa of Fabricius weight ratios in DEXF treated 
chickens were significantly decreased in experiments 2 and 3 when compared to non-treated 
controls (Tables 1 and 3). 
  Results of the evaluation of DEXF (0.57 ppm) on total leukocyte counts (WBC), and 
percentages of heterophils, lymphocytes, monocytes, eosinophils, and basophils of peripheral 
blood of 10-day-old broilers from experiment 2 are summarized in Table 4.  Significant increases 
were observed in the percentages of heterophils, eosinophils and H/L ratio, as well as a 
significant decrease difference in the percentage of lymphocytes in the DEX treated chickens 
when compared with control chickens (Table 4).  Increased H/L from 0.55±0.21 in non-treated 
chickens to 1.34±0.39 in DEXF chickens was consistent with previous reports describing effects 
of dexamethasone on leukocyte counts.  However, an increase in eosinophils from 0.08±0.04 in 
control birds to 0.31±0.1 was unexpected, but may be due to lack of differentiation of 
granulocytes by the cell sorter (personal communication, Sonia Tsai). 
 
48 
 
F. DISCUSSION 
Blood corticosteroid concentration is a known indicator of stress in chickens, and the 
glucocorticoid dexamethasone is well-studied as an inducer of cell-mediated 
immunosuppression, especially related to decreased disease resistance (Rose, 1970; Gross and 
Siegel, 1983; Huff et al., 1998).  Furthermore, dexamethasone has been used as a mediator of 
opportunistic diseases in poultry including colibacillosis, turkey osteomyelitis, and bacterial 
chondronecrosis with osteomyelitis (Bayyari et al., 1997; Huff et al., 1998; Wideman and 
Pevzner, 2012).  Manifestation of these conditions may be related to decreased macrophage 
bactericidal activity (Schaffner, 1985; Schaffner and Schaffner, 1988), and all require 
translocation of bacteria from the gastrointestinal tract into blood circulation, where they 
eventually manifest.  Stress is also a well-known immunosuppressing event that can lead to 
opportunistic infections in both humans and animal models, which may be related to depression 
of pituitary adrenocortical function (Westerhof et al., 1996).  The pathophysiology of stress-
induced intestinal disturbances is known to be mediated by corticotrophin releasing factor, which 
increases intestinal paracellular permeability via mast cell dependent release of TNF-α and 
proteases (Taché and Perdue, 2004; Teitelbaum et al., 2008).  In these permeability experiments, 
the progressive detection of FITC-D in serum (Figure 1, Tables 1 and 3) is consistent with 
leakage from the lumen and suggests the presence of a change in paracellular permeability.  
Alterations in enteric mucosal permeability are connected with bacterial translocation in 
the portal and/or systemic circulation in several types of intestinal permeability syndromes 
leading  to systemic bacterial infections (Seki and Schnabl, 2012; Ilan, 2012).  Fluoroscein 
isothiocyanate dextran is a molecule (3-5 kDa) which is not normally absorbed by an intact 
gastrointestinal tract barrier. However, when conditions disrupt tight junctions between epithelial 
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cells, FITC-D molecules can enter circulation, as demonstrated by an increase in trans-mucosal 
permeability associated with DEX treated chickens and elevated serum levels of FITC-D after 
oral administration (Yan et al., 2009; Tellez et al., 2014).  The fact that elevated permeability 
was significantly higher in DEX treated chickens in all experiments suggest that this stress 
practice has a strong impact on the epithelial barrier, altering gut permeability in broiler chickens 
(Figure 1, Tables 1 and 3). 
In the present study, a significant increase in total detectable aerobic bacteria in the liver 
was observed in DEXF treated chickens when compared with control chickens, which could be 
related to either decreased bactericidal activity of macrophages, or increased epithelial 
permeability (Tables 1 and 3).  Furthermore, stress-induced bursal atrophy has been suggested to 
be caused by an increased corticosteroid production (Huff et al., 1999).  In the present study, 
BW, BWG and the relative lymphoid organ (bursa of Fabricius and spleen combined) were 
significantly reduced in DEXF treated chickens (Tables 1 and 3), and these results are in 
agreement with previous investigations (Gross and Siegel, 1983; Huff et al., 1999; Shini et al., 
2009; Wideman and Pevzner, 2012). 
Increased H/L is considered an indicator of chronic stress in birds (Gross and Siegel, 
1983), which was consistent with decreased levels of lymphocytes in chicken blood samples and 
increased heterophils in response to DEXF treatment. This suggests that administration of 
dexamethasone in feed may be an acceptable manner for delivery of glucocorticoids to chickens 
to mimic stress and provide a means by which to study the effects of stress conditions on enteric 
inflammation parameters such as mucosal integrity.  Furthermore, this model has potential to 
serve as a method of induction of diseases for which bacterial translocation is a component of 
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pathogenesis, such as colibacillosis, spondylolisthesis, or bacterial chondronecrosis with 
osteomyelitis. 
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Table 1 Evaluation of administration of dexamethasone in feed (DEXF) on serum FITC-D, 
bacterial translocation, body weight and lymphoid organ weight in birds from Experiment 2. 
Treated chickens received control feed supplemented with 0.57 ppm of dexamethasone d4-10.  
On d10 chickens in both groups were gavaged with FITC-d (4.16 mg/kg) and blood samples 
were collected 2.5h later. Lymphoid organ ratio includes bursa and spleen and is expressed as a 
percentage of body weight. All samples were collected on d10. Data are expressed as mean ± 
standard error. 
a–b 
Means within a column with different superscripts differ (P< 0.05).   
 Serum 
FITC-D 
(µg/mL) 
Total Liver 
Aerobic Bacteria 
(Log10 cfu/g) 
Final BW 
(g) 
BWG 
(g) 
Lymphoid 
Organ Ratio 
(%) 
Control 0.22 ± 0.01
b
 0.00 ± 0.00
b
 171.44 ± 2.87
a
 103.28 ± 2.82
a
 0.24 ± 0.01
a
 
DEXF 0.29 ± 0.03
a
 1.26 ± 0.45
a
 152.07 ± 2.09
b
 84.37 ± 1.57
b
 0.16 ± 0.01
b
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Table 2 Evaluation of administration of dexamethasone in feed on total leukocyte counts 
(WBC), and percentages of heterophils, lymphocytes, monocytes, eosinophils, and basophils of 
peripheral blood, Experiment 2. Treated chickens received control feed supplemented with 
0.57ppm d4-10.  Data are expressed as mean ± standard error. 
a–b 
Means within a row with 
different superscripts differ (P<0.05).  
 Control Dexamethasone 
WBC (×10
3
/µL) 17.20 ± 4.85
a 
21.62 ± 2.51
a
 
Heterophils (%) 24.02 ± 7.08
b
 41.6 ± 6.23
a
 
Lymphocytes (%) 59.58 ± 8.26
a
 34.21 ± 8.06
b
 
Monocytes (%) 12.51 ± 2.17
a
 9.82 ± 1.63
a
 
Eosinophils (%) 0.08 ± 0.04
b
 0.31 ± 0.1
a
 
Basophils (%) 2.84 ± 0.35
a
 3.02 ± 0.20
a
 
Heterophil:Lymphocyte 0.55 ± 0.21
b
 1.34 ± 0.39
a
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Table 3 Evaluation of administration of dexamethasone in feed (DEXF) on serum FITC-D, 
bacterial translocation, body weight and lymphoid organ weight in birds from Experiment 2. 
Treated chickens received control feed supplemented with 0.57 ppm of dexamethasone d4-10.  
On d10 chickens in both groups were gavaged with FITC-d (4.16 mg/kg) and blood samples 
were collected 2.5h later. Bursa and spleen weight rations are expressed as a percentage of body 
weight. All samples were collected on d10. Data are expressed as mean ± standard error. 
a–b 
Means within a column with different superscripts differ (P< 0.05).   
 
  
 
Serum 
FITC-D 
(µg/mL) 
Total Liver 
Aerobic Bacteria 
(Log10 cfu/g) 
Final BW (g) 
Bursa Weight 
Ratio (%) 
Spleen Weight 
Ratio (%) 
Control 0.33 ± 0.01
b
 0.00 ± 0.0
b
 225.40 ± 4.75
a
 0.15 ± 0.006
a
 0.11 ± 0.007
a
 
DEXF 0.63 ± 0.04
a
 2.58 ± 0.35
a
 146.71 ± 2.42
b
 0.07 ± 0.005
b
 0.07 ± 0.006
b
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Figure 1  Levels of serum FITC-D after treatment with Dexamethasone in feed (DEXF) at three 
different levels or injection (DEXINJ).  Treated feed was provided d4-d10 and injections were 
administered every other day from d4-d10.  FITC-D (4.17 mg/kg) was administered by oral 
gavage 2.5h before blood sample collection.  Truncation of data included removal of one sample 
(<2SD from mean) from each DEXF and DEXINJ group. Treatments with different superscripts 
indicate statistical difference (P<0.05). 
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V. CONCLUSIONS 
 
Barrier function is a critical aspect of gut heath.  On a daily basis, the intestine is exposed 
to a nearly unlimited number of antigens and potential insults, including dietary components, 
toxins, and commensal and pathogenic microorganisms. The GIT serves as a selective barrier to 
take up nutrients and fluids into the body, while excluding undesirable molecules and pathogens.  
Hence, proper gut barrier function is essential to maintain optimal health and balance throughout 
the body and represents the first line of defense against these foreign antigens from the 
environment.  Oxidative stress, poorly digestible protein or energy sources and coccidiosis are 
some examples that can cause gut barrier failure. However, as a consequence of the removal of 
antimicrobial growth promoters, new multifactorial diseases causing enteritis and gut disorders 
of unknown origin have emerged in broilers, causing negative impacts in health and 
performance.  Additionally, commercial poultry are commonly exposed to a plethora of stressors 
that can induce a variety of changes in normal gastrointestinal function, including changes in gut 
motility and permeability, as well as alterations in ion, fluid, and mucus secretion and 
absorption. These changes have been linked to Mast cells which are important effectors of the 
brain-gut axis and which translate the stress signals into the release of a wide range of 
neurotransmitters and pro-inflammatory cytokines, with dramatic effects on gastrointestinal 
physiology.   In this thesis, we evaluated several intestinal inflammation models to induce gut 
leakage by different methods in broiler chickens using FITC-d as a marker.   In chapter one, we 
evaluate the dose titration of FITC-d for optimal measurement of enteric inflammation in broiler 
chicks using the following models: a) 24h FR; b) DSS; or c) RBD.  All three models evaluated, 
FR, DSS, and RBD increased significantly (P < 0.05) serum concentrations of FITC-d, 
suggesting their value for enteric inflammation models, and that FITC-d absorption from the GIT 
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into the circulation may be a good indicator of permeability.  In chapter two, a series of 
experiments were conducted to evaluate the effect of dexamethasone (DEX) treatment in feed on 
systemic (serum) FITC-d levels, total numbers of aerobic bacteria in liver as an index of 
bacterial translocation (BT), differential white blood cell counts, and immune organs in broiler 
chickens.  DEX-treated chickens showed a significant increase in FITC-d serum levels and BT, 
again indicating that stress increased paracellular leakage across the gut epithelium associated 
with dissolution of tight junctions. Additionally, heterophil/lymphocyte ratio was significantly 
increase and relative spleen and bursa of Fabricius weight ratios were significantly decreased in 
DEX-treated chicks.  The results of these studies provide the baseline of an enteric inflammation 
model in broiler chickens to further evaluate anti-inflammatory properties of nutraceuticals as 
alternatives to the use of AGP. 
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APPENDIX 
 
